September 2021
We are excited to launch a brand new webinar initiative, the MEGIN Masterclass, featuring an array of Key Opinion and Thought Leaders in the field. Each webinar will focus on a different topic, offering an opportunity to learn in more detail about the latest research and clinical cases. This will be a great forum to learn from some of the best minds in MEG, with time for questions, to connect with specialists and the wider, global community.
MEGIN Masterclass with Fernando Maestú:
“Functional networks impairment along the process of AD: prediction value and resilience factors”
In this complimentary webinar, Professor Fernando Maestú will discuss a series of studies, which mainly used MEG to record the resting-state activity and a memory task in patients with Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), and in healthy subjects at the preclinical stage or at risk for developing dementia. All these findings together indicate that hyper synchronization of the brain networks could be an excellent non-invasive biomarker for tracking the disease and evaluate interventions.*
* The MEGIN Masterclasses content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This particular Masterclass is related to research only.
Webinar date:
September 29, 2021 14:00 JST (06:00AM BST)
To register please click HERE
MEGIN continues to deliver excellent global customer care
MEGIN’s dedicated Customer Care Team has been extremely busy. We have recently installed a TRIUX™ neo at Amsterdam University Medical Centers, location Amsterdam, Netherlands.
Despite travel still restricted, MEGIN continues to globally install new devices, conduct routine service and maintenance, and deliver world-class training to our customers. We are very proud of our team for navigating this “new normal,” and continuing their excellent work.
Image 1: Installation at Amsterdam University Medical Centers, Amsterdam, Netherlands
MEGIN Customer Spotlights
Dimitrios Pantazis, McGovern Institute for Brain Research at MIT discussing utilization of MEG
Dimitrios Pantazis, the Principal Research Scientist and Director of the MEG Lab at the McGovern Institute for Brain Research at MIT discusses his two areas of research focus: human visual recognition and Alzheimer’s disease, as well as the future of MEG and predicted advances in machine learning and AI.
To watch further episodes of MEGIN Spotlights please click here
MEG Community News
These news items are selected only for information purposes for our customers and MEGIN assumes no responsibility for their content.
Investigating brain mechanisms underlying natural reading by co-registering eye tracking with combined EEG and MEG
Click here to read this interesting study
Follow us on preferred social media channels for the latest news
www.megin.fi